ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,160Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 1300

$490K Total Retail Price of All Prescriptions

Rank: 33 out of 1300

469 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 469 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

10% of this provider’s 469 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 7,227 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
LEVOTHYROXINE SODIUM 573 422 1 1
OMEPRAZOLE 352 209 2 4
LISINOPRIL 348 296 3 2
HYDROCODONE-ACETAMINOPHEN 332 140 S3 4 5
TRAMADOL HCL 304 192 5 17
SIMVASTATIN 262 244 6 3
WARFARIN SODIUM 237 215 7 9
GABAPENTIN 230 119 8 15
POTASSIUM CHLORIDE 228 212 9 18
FUROSEMIDE 226 193 10 8
METOPROLOL TARTRATE 217 185 11 11
MELOXICAM 173 83 12 47
AMLODIPINE BESYLATE 168 157 13 6
METFORMIN HCL 165 120 14 7
CITALOPRAM HBR 135 91 15 19
ALENDRONATE SODIUM 133 96 16 20
DONEPEZIL HCL 130 118 17 32
HYDROCHLOROTHIAZIDE 119 99 18 10
TAMSULOSIN HCL 112 81 19 25
CYCLOBENZAPRINE HCL 108 41 R 20 58
METOPROLOL SUCCINATE 108 87 20 24
ZOLPIDEM TARTRATE 104 74 22 14
FLUTICASONE PROPIONATE 100 55 23 30
AZITHROMYCIN 99 71 24 79
BACLOFEN 94 48 25 100
FENTANYL 93 64 S2 26 56
CYMBALTA 89 44 27 44
NAMENDA 83 83 28 51
SERTRALINE HCL 81 61 29 26
CARVEDILOL 81 57 29 38
VENLAFAXINE HCL ER 76 47 31 69
AMITRIPTYLINE HCL 76 52 R 31 63
LISINOPRIL-HYDROCHLOROTHIAZIDE 75 62 33 21
CIPROFLOXACIN HCL 75 54 33 87
ADVAIR DISKUS 74 37 35 41
FAMOTIDINE 73 58 36 73
ATENOLOL 72 51 37 12
LOSARTAN POTASSIUM 71 59 38 16
PREDNISONE 71 34 38 40
TRIAMTERENE-HCTZ 71 38 38 54
POLYETHYLENE GLYCOL 3350 61 33 41 65
DIGOXIN 61 61 41 48
LANTUS 60 47 43 43
METOCLOPRAMIDE HCL 59 47 44 143
ATORVASTATIN CALCIUM 59 55 44 13
LAMOTRIGINE 58 26 46 119
ALLOPURINOL 56 38 47 29
CEFPROZIL 54 40 48 328
SPIRIVA 54 39 48 45
RANITIDINE HCL 54 34 48 27
VENLAFAXINE HCL 52 37 51 152
NEXIUM 51 36 52 46
METHYLPREDNISOLONE 50 34 53 257
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 18, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.